Apparent mineralocorticoid excess as a side effect of ketoconazole therapy in a patient with Cushing's disease

Clin Endocrinol (Oxf). 2020 Jan;92(1):80-83. doi: 10.1111/cen.14118. Epub 2019 Nov 15.

Authors

Manuel Luque-Ramírez^{1

2

3}, Andrés E Ortiz-Flóres², Lía Nattero-Chávez^{1

2}, Héctor F Escobar-Morreale^{1

2

3}

Affiliations

¹ Department of Endocrinology and Nutrition, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), CIBER Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Madrid, Spain.
² Diabetes, Obesity and Human Reproduction Research Group, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), CIBER Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Madrid, Spain.
³ University of Alcalá, Madrid, Spain.

PMID: 31667853
DOI: 10.1111/cen.14118

No abstract available

Keywords: apparent mineralocorticoid excess; deoxycorticosterone; hypercortisolism; ketoconazole; side effect.

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

14-alpha Demethylase Inhibitors / adverse effects*
Female
Humans
Ketoconazole / adverse effects*
Middle Aged
Mineralocorticoid Excess Syndrome, Apparent / chemically induced*
Pituitary ACTH Hypersecretion / drug therapy*

Substances

14-alpha Demethylase Inhibitors
Ketoconazole